Dr Sarah Needleman

Job title
Consultant clinical oncologist.
Lead for radiotherapy.
Director of medical education.
Qualifications
MBBS BSc MRCP FRCR MSc PGCert FHEA
GMC Number
6054260
Contact details
PA/secretary phone number: Agnieszka McDonnell: 020 7472 6767
PA/secretary email address: agnieszka.mcdonnell1@nhs.net
Private practice phone number: Angie Fisher - 020 7830 2169
Private practice email address: angiefisher@nhs.net
Related services
Biography
Dr Sarah Needleman is principal investigator for breast or urology cancer trials and is committed to delivering high-quality, individualised patient care.
She has an MSc in oncology and has published oncological manuscripts related to breast or pelvic malignancy.
She is passionate about education, and has been awarded education fellowships, undertaken educational research and published related manuscripts.
Publications
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Attard G, Murphy L, Clarke NW, Cross W, et al Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators.Lancet. 2022 Jan 29;399(10323):447-460.
A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study. Afaq A, Payne H, Davda R, Hines J, Cook GJR, Meagher M, Priftakis D, Warbey VS, Kelkar A, Orczyk C, Mitra A, Needleman S, Ferris M, Mullen G, Bomanji J.J Nucl Med. 2021 Mar 19;62(12):1727-34
Neutrophil-to-lymphocyte ratio (NLR) as a prognostic indicator of treatment response to novel hormones in metastatic castrate-resistant prostate cancer: Real-world data from a single institution E Scott, K Pasciuti, M Kubiak, G Marks, S Needleman, K Smith, M Prentice Journal of Clinical Oncology 39, no. 6_suppl (February 20, 2021) 52-52.
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. Lancet Oncol. 2018 Nov;19(11):1516-1529. Lancet Oncol. 2018 Dec;19(12):e668. PMID:30337220.Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, Clarke J,Kunkler IH, Russell NS; MRC SUPREMO trial UK investigators.
Radiation hazards in pregnancy and methods of prevention Needleman SJ, Powell ME Best Practice & Research Clinical Obstetrics & Gynaecology Oct 2015
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer JS Vaidya, M Bulsara, M Baum, F Wenz, S Massarut et al- BMJ, 2020
Hormone Receptor Positive Early Breast Cancer: What Role for Aromatase Inhibitors? Dewdney A, Needleman S Clinical Medicine Reviews in Oncology 2010
Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer. Needleman SJ, Tobias JS. Expert Rev Anticancer Ther. 2008 Dec;8(12): 1871-81.
Aromatase inhibitors in early hormone receptor-positive breast cancer : what is the optimal initiation time for the maximum benefit? Needleman SJ, Tobias JS. Drugs. 2008;68(1):1-15
The Shift Towards Digital Appointments: the response to Covid -19 Affecting Uro-Oncology E Scott, M Kubiak, S Needleman, G Marks, , K Smith, M Prentice Clinical Oncology supplement, July 2020
A Single-centre Audit of Time from Surgery to Adjuvant Radiotherapy in Breast Cancer Patients Treated at the Royal Free Hospital K Durno, R Chandler, S Needleman. Clinical Oncology supplement, 2020
A Single-centre, Retrospective Audit of Adherence to the Updated Royal College of Radiology (RCR) Guidelines for the Treatment Duration of Adjuvant Breast K Durno, A Chander, SNeedlema. Clinical Oncology Supplement, 2020
Post-mastectomy Radiotherapy Bolus Across the North and East London Radiotherapy Network E Scott, S Needleman - Clinical Oncology Supplement,, 2020
The Use of the Virtual Environment for Radiotherapy Training (VERT) Improves Understanding and Reduces Anxiety in Patients Undergoing Breast Radiotherapy: a single centre experience V Gandhi, S Kuthpady, S Needleman – Clinical Oncology Supplement 2020
Deep Inspiratory Breath Hold Technique to Reduce Cardiotoxicity when Delivering Left Breast/Internal Mammary Chain Radical Radiotherapy: Obstacles to compliance. A Chander, J Iqbal, S Needleman - Clinical Oncology Supplement, 2019
Use of Virtual Reality in patient education improves understanding of radiotherapy treatment and reduces anxiety: a retrospective single-centre study NCRI 2018 Vanita Gandhi, Shriniva Kuthpady, Sarah Needleman
Virtual Reality: Enhancing the prostate cancer patient’s experience of radiotherapy Vanita Gandhi, Kuthpady Shrinivas, Sarah Needleman BMJ Leader 2018 The use of complementary and alternative medicines (CAM) in brain tumour patients Needleman SJ ,Wasim Z, Kassab S, Short SC European Association for Neurooncology (EANO) Sept 2010
Medical Education Publications
The validity of the Annual review of competence progression : a qualitative study of the perceptions of junior doctors and their trainers Viney R, Rich A, Needleman S, Griffin A, Woolf K, Journal of the Royal Society of Medicine 2017 Jan 1
“You can’t be a person and a doctor”. The work-life balance of doctors in training: a national qualitative study Rich A, Viney R, Needleman S, Griffin A, Woolf K British Medical Journal Open Dec 2016
‘Causes of differential attainment in UK postgraduate medical training: a national qualitative study Woolf K, Rich A, Viney R, Needleman S, Griffin A British Medical Journal Open Nov 2016
‘Fair Training Pathways for All: Understanding Experiences of Progression’ Woolf K, Rich A, Viney R, Rigby M, Needleman S, Griffin A General Medical Council report Jul 2016
A pilot of virtual patient clerking in oncology Myrto Kastrisiou, Justina Cheh Juan Tai, Liang Zhi Wong, Neha Chopra, Mark Prentice, Sarah Needleman The Clinical Teacher NOV 2021
Review of carousel-based stations at a regional clinical oncology training day The Clinical Teacher NOV 2020 Dr Emily Scott, Dr Anjali Chander, Dr Gillian Marks, Dr Sarah Needleman
Using role models to inspire the next generation of female leaders Needleman S, Gafson I UCL Partners Education Conference 2016 Educational innovation through partnership Nov 2016
What women perceive makes a ‘good leader’ Needleman S, Gafson I International Medical Women’s Federation (MWF) Autumn Conference 2016 Winner of the Elizabeth Garrett Anderson prize Nov 2016